Dignitana publish interim financial report for Q2 ...
About DignitanaDignitana develops a patented scalp cooling system, DigniCap®, that reduces chemotherapy-induced hair loss. Dignitana's patented DigniCap® system has demonstrated excellent scientific results in clinical studies. More than eight out of ten treated patients were able to retain enough of their hair to eliminate the need for a wig.
About DigniCap®DigniCap® provides a reliable method of continuous scalp cooling with high efficacy and an acceptable level of patient comfort. The system consists of a form-fitting silicone cap connected to a cooling and control unit. An elastic, insulating outer cap made of neoprene is used to ensure the best fit and treatment temperature. Please visit our new website for more product information www.dignicap.com.
Investor relationsDignitana is a Swedish medical technology company listed on the NASDAQ OMX First North stock exchange. The company is currently focusing on a widespread market launch of the DigniCap® system – a product that counteracts chemotherapy-related hair loss in cancer patients and significantly contributes to improving patient well being and quality of life.
DEMAND FOR DIGNICAP® SYSTEM REMAINS STRONG AS 32 U.S. MEDICAL CENTERS ADD DIGNITANA’S FDA-CLEARED MEDICAL SCALP COOLING DEVICE TO THEIR CANCER CARE SERVICES
DEMAND FOR DIGNICAP® SYSTEM REMAINS STRONG AS 32 ...
DEMAND FOR DIGNICAP® IS STRONG AS DIGNITANA BRINGS FDA-CLEARED MEDICAL SCALP COOLING DEVICE TO MORE U.S. CANCER CENTERS
Dignitana AB announced today that the DigniCap® s...
New AddressWe have moved. Our new address is
SE-226 60 Lund.